Hydrazinecarboxylicacid, 2-(1-phthalazinyl)-, ethyl ester, hydrochloride (1:1) cas no:3778-76-5
Synonyms: Carbazicacid, 3-(1-phthalazinyl)-, ethyl ester, monohydrochloride (8CI);Hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester, monohydrochloride(9CI); 2-Carbethoxy-1-(1-phthalazinyl)hydrazine hydrochloride; Apirachol;Apiracohl; Apredor; Apride; Atapren; BT 621; Binazin; Binazine; CEPH;Ecarazine; Ecarazine hydrochloride; Illcut;N-Carbethoxy-N'-(1-phthalazino)hydrazine hydrochloride;N-Carbethoxy-N'-phthalazinohydrazide hydrochloride;N1-Carboethoxy-N1-hydrazinophthalazine; Propat; Todralazine hydrochloride
NameHydrazinecarboxylicacid, 2-(1-phthalazinyl)-, ethyl ester, hydrochloride (1:1)
CAS3778-76-5
SynonymsCarbazicacid, 3-(1-phthalazinyl)-, ethyl ester, monohydrochloride (8CI);Hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester, monohydrochloride(9CI); 2-Carbethoxy-1-(1-phthalazinyl)hydrazine hydrochloride; Apirachol;Apiracohl; Apredor; Apride; Atapren; BT 621; Binazin; Binazine; CEPH;Ecarazine; Ecarazine hydrochloride; Illcut;N-Carbethoxy-N'-(1-phthalazino)hydrazine hydrochloride;N-Carbethoxy-N'-phthalazinohydrazide hydrochloride;N1-Carboethoxy-N1-hydrazinophthalazine; Propat; Todralazine hydrochloride
Molecular FormulaC11H12 N4 O2 . Cl H
Molecular Weight286.75
Hazard Xn: Harmful;
Risk R20/21/22
Safety
Poison by ingestion, subcutaneous, intravenous, and intraperitoneal routes. An experimental teratogen. Mutation data reported. When heated to decomposition it emits toxic fumes of NOx and HCl. See also ESTERS.Safety information of Todralazine hydrochloride hydrate (CAS NO.3778-76-5):
Hazard Codes
Xn
Risk Statements
20/21/22 Harmful by inhalation, in contact with skin and if swallowed
Safety Statements
36 Wear suitable protective clothing
WGK Germany 3
RTECS FE2778600
1. |
|
mmo-sat 500 µg/plate
|
|
RCOCB8 Research Communications in Chemical Pathology and Pharmacology. 49 (1985),415. |
2. |
|
mma-sat 1 mg/plate
|
|
RCOCB8 Research Communications in Chemical Pathology and Pharmacology. 49 (1985),415. |
3. |
|
orl-rat LD50:598 mg/kg
|
|
YIKUAO Yamaguchi Igaku. 18 (1969),29. |
4. |
|
ipr-rat LD50:200 mg/kg
|
|
YIKUAO Yamaguchi Igaku. 18 (1969),29. |
5. |
|
scu-rat LD50:466 mg/kg
|
|
YIKUAO Yamaguchi Igaku. 18 (1969),29. |
6. |
|
ivn-rat LD50:240 mg/kg
|
|
YIKUAO Yamaguchi Igaku. 18 (1969),29. |
7. |
|
orl-mus LD50:516 mg/kg
|
|
OYYAA2 Oyo Yakuri. Pharmacometrics. 3 (1969),97. |
8. |
|
ipr-mus LD50:501 mg/kg
|
|
YIKUAO Yamaguchi Igaku. 18 (1969),29. |
9. |
|
scu-mus LD50:319 mg/kg
|
|
OYYAA2 Oyo Yakuri. Pharmacometrics. 3 (1969),97. |
10. |
|
ivn-mus LD50:300 mg/kg
|
|
OYYAA2 Oyo Yakuri. Pharmacometrics. 3 (1969),97. |
11. |
|
orl-rbt LD50:399 mg/kg
|
&nbs |